Order Entry
Northern Ireland
ContactUsLinkComponent
 
Mouse recombinant IDO (from E. coli)
  PRSI92-696
 :  
Mouse recombinant IDO (from E. coli)
  PRSI92-696
 :  

Some Products May Appear Restricted

To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.

If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)

 

If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation;  additional documentation will be requested for these items prior to shipment. 

 

  • Pk:
    50 µG
  • Protein/peptide type:
    Recombinant
  • Source:
    E. coli
  • Species:
    Mouse
  • Tag sequence:
    N-6 His tag
  • Storage conditions:
    Store at −20 °C, stable for 6 months after receipt. Please minimize freeze-thaw cycles.
  • Protein synonyms:
    IDO1|IDO|Indoleamine 2|Indole 2|3-dioxygenase 1|IDO-1|3-dioxygenase|INDO
  • Protein/peptide name:
    IDO
  • Purity:
    > 95% as determined by reducing SDS-PAGE
  • Molecular weight:
    47.1 kD
  • Sequence:
    Met1-Pro407
  • Formulation:
    Supplied as a 0.2 um filtered solution of 20mM Sodium Acetate, 150mM NaCl and 20% Glycerol, pH4.5.. Always centrifuge tubes before opening. Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100 ug/ml. Dissolve the lyophilized protein in ddH2O. Please aliquot the reconstituted solution toPTTLGTIHSPEDVIKALADHHHHHHHHHE

 

 

Indoleamine 2,3-dioxygenase (IDO) is a heme enzyme that initiates the oxidative degradation of the least abundant, essential amino acid, l-tryptophan, along the kynurenine pathway. This protein is normally expressed in the dendritic cells, macrophages, microglia, eosinophils, fibroblasts, endothelial cells, and most tumour cells. IDO activity is associated with immunosuppression and immune attenuation. Several studies showed that IDO can contribute to immune escape when expressed directly in tumour cells or when expressed in immunosuppressive antigen presenting cells such as tolerogenic dendritic cells or tumour associated macrophages. IDO also is a promising therapeutic target for the treatment of cancer, chronic viral infections, and other diseases characterised by pathological immune suppression.

Fusion-Tag: N-6 His tag

This recombinant protein can be used for biological assays. For research use only.